摘要
目的 研究应用利培酮治疗儿童精神分裂症的疗效和安全性。方法 对36例9~15岁经CCMD-3诊断为儿童精神分裂症的患者,应用利培酮治疗12周,平均起始剂量(0.86±0.05)mg/日,平均治疗剂量为(3.44±1.08)mg/日,采用简明精神病量表(BPRS)评定疗效,锥体外系症状量表(ESRS)和实验室检查评价不良反应。结果 利培酮对儿童精神分裂症各种症状均有较好疗效,显效率为83%,有效率94.4%,不良反应主要有轻度的睡眠增多和锥体外系反应,其他不良反应少见。结论 利培酮对儿童精神分裂症疗效较好,不良反应少,依从性较好,值得推广使用。
Objective: To observe the effect and safety of risperidone in treating child schizophrenic patiens. Methods: 36 patiens (aged betwen 9-15 years) met CCMD-3 criteria for childhood schizophrenia were recruited. The duration of risperidone treatment was 12 weeks with (0.86±0.05)mg/d of average initial dose and (3.44±1.08)mg/d of average therapeutic dose. BPRS was used to evaluate therapeutic effect and ESRS, laboratery tests were done for side effect assessment. Results: Risperidone had satisfactory effect on the various symptoms of childhood schizophrenia, 94.4% of the patients were improrld, in which 83% much improred. The main side effects were slight drowsiness and ESP. Conclusion: Rsiperidone has satisfactory effect in the treatment of chilhood schiozphrenia, with less and slight side effects, superior compliance. It is worthy to be recommended for clinical treatment.
出处
《上海精神医学》
北大核心
2003年第5期288-289,共2页
Shanghai Archives of Psychiatry
关键词
利培酮
精神分裂症
儿童
Risperidone Schizophrenia Children